Ceftobiprole medocaril

From WikiMD.org
Jump to navigation Jump to search

Ceftobiprole medocaril

Ceftobiprole medocaril (pronunciation: sef-toe-bi-prole me-do-ca-ril) is a broad-spectrum antibiotic used in the treatment of a variety of bacterial infections. It is a prodrug of the active compound ceftobiprole.

Etymology

The name "Ceftobiprole medocaril" is derived from its parent compound "ceftobiprole", which is a third-generation cephalosporin antibiotic. The suffix "-medocaril" indicates that it is a prodrug, which is a biologically inactive compound that can be metabolized in the body to produce an active drug.

Usage

Ceftobiprole medocaril is used to treat a wide range of bacterial infections, including skin and soft tissue infections and pneumonia. It is particularly effective against methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa.

Mechanism of Action

As a prodrug, ceftobiprole medocaril is converted into its active form, ceftobiprole, in the body. Ceftobiprole inhibits the synthesis of the bacterial cell wall, leading to cell death.

Related Terms

External links

Esculaap.svg

This WikiMD dictionary article is a stub. You can help make it a full article.


Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski